Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3407-3414, August 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, P.
Right arrow Articles by Plunkett, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, P.
Right arrow Articles by Plunkett, W.

Biochemical Characterization of the Protein Activity Responsible for High Molecular Weight DNA Fragmentation during Drug-induced Apoptosis1

Peng Huang2, Kalpana Ballal and William Plunkett

Department of Clinical Investigation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Cleavage of cellular DNA into high molecular weight (predominantly 50 kb) fragments is an early event during apoptosis. We previously reported that this fragmentation was a Ca2+-independent process during apoptosis, which was induced by anticancer agents in human leukemia cells. The present study demonstrated that a high molecular weight DNA fragmentation activity (HDFA) was induced in the drug-treated cells and, upon fusion of the drug-treated cells with untreated target cells prelabeled with [14C]thymidine, caused fragmentation of the labeled DNA in the target cells. Furthermore, extracts of the drug-treated cells caused high molecular weight DNA fragmentation in nuclei isolated from untreated cells. Biochemical characterization of HDFA revealed the following properties: HDFA was proteinaceous in nature, as evidenced by its inactivation by heating or by digestion with proteinase K; HDFA required Mg2+ for optimal activity but was inhibited by Zn2+ and K+; HDFA was active in vitro at pH 6.0–8.0 and was inactive under more acidic conditions (pH < 6.0); addition of ATP (0.5–2 mM) substantially potentiated HDFA activity in isolated nuclei; and HDFA was not inhibited by actin (an inhibitor of DNase I) but was inhibited by the extracts from K562 cells, which were resistant to drug-induced apoptosis. The specific inhibitor of cysteine proteases (interleukin 1ß-converting enzyme protease family) blocked the generation of drug-induced high molecular weight DNA fragmentation in whole cells, whereas in isolated nuclei, the cysteine protease inhibitors did not prevent the cleavage of chromatin by exogenous HDFA. These results suggest that, once HDFA is activated during apoptosis, it does not require the presence of cysteine proteases for its endonucleolytic activity and that the cysteine proteases may be involved in the apoptotic process upstream of the activation of HDFA in whole cells.

1 This work was supported in part by Grants CA28596, CA32839, and CA55164 from the National Cancer Institute, the Department of Health and Human Services, and by Grant DHP-1 from the American Cancer Society.

2 To whom requests for reprints should be addressed, at Department of Clinical Investigation, Box 71, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. Phone: (713) 792-7742; Fax: (713) 794-4316.

Received 2/ 3/97. Accepted 6/18/97.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Otake, A. Mims, and D. J. Fernandes
Merbarone Induces Activation of Caspase-Activated DNase and Excision of Chromosomal DNA Loops from the Nuclear Matrix
Mol. Pharmacol., April 1, 2006; 69(4): 1477 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. S. Lawrence, M. A. Davis, A. Hough, and A. Rehemtulla
The Role of Apoptosis in 2',2'-Difluoro-2'-deoxycytidine (Gemcitabine)-mediated Radiosensitization
Clin. Cancer Res., February 1, 2001; 7(2): 314 - 319.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
D. E. Pritchard, J. Singh, D. L. Carlisle, and S. R. Patierno
Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells
Carcinogenesis, November 1, 2000; 21(11): 2027 - 2033.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Li, M. Bhuiyan, S. Alhasan, A. M. Senderowicz, and F. H. Sarkar
Induction of Apoptosis and Inhibition of c-erbB-2 in Breast Cancer Cells by Flavopiridol
Clin. Cancer Res., January 1, 2000; 6(1): 223 - 229.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. O. Rodriguez Jr. and V. Gandhi
Arabinosylguanine-induced Apoptosis of T-Lymphoblastic Cells: Incorporation into DNA Is a Necessary Step
Cancer Res., October 1, 1999; 59(19): 4937 - 4943.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T.-K. Li, A. Y. Chen, C. Yu, Y. Mao, H. Wang, and L. F. Liu
Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress
Genes & Dev., June 15, 1999; 13(12): 1553 - 1560.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.